1. Government of Canada. Opioid and stimulant-related harms in Canada. Published March 2021. Accessed April 14, 2021. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/graphs?index=477
2. Canadian Centre on Substance Use and Addiction. Impacts of the COVID-19 pandemic on substance use treatment capacity in Canada. Accessed February 11, 2021. https://www.ccsa.ca/sites/default/files/2020-12/CCSA-COVID-19-Impacts-Pandemic-Substance-Use-Treatment-Capacity-Canada-2020-en.pdf
3. Ontario Drug Policy Research Network; Office of the Chief Coroner for Ontario/Ontario Forensic Pathology Service; Public Health Ontario; Centre on Drug Policy Evaluation. Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic. Published November 2020. Accessed April 14, 2021. https://www.drugsandalcohol.ie/33326/1/Opioid-Death-Report_FINAL-2020NOV09.pdf
4. US Centers for Disease Control and Prevention. Overdose deaths accelerating during COVID-19. Published December 17, 2020. Accessed January 18, 2021. https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html
5. Department of Information Evidence and Research. WHO methods and data sources for global burden of disease estimates 2000-2015. Published January 2017. Accessed April 14, 2021. https://www.who.int/healthinfo/global_burden_disease/GlobalDALYmethods_2000_2015.pdf